Introduction
============

Mineralization plays a crucial role during normal development and replacement of cartilaginous skeleton via endochondral ossification. Mineralization of growth plate cartilage is restricted to terminally differentiated chondrocytes, and thus the mineralization process must be under cellular control ([@bib25]; [@bib29]). In general, mineralization is restricted to skeletal tissues and teeth, where it is required for the proper function of these tissues. However, uncontrolled (pathological) mineralization can occur in all soft tissues. For example, excessive mineral deposition accompanies osteoarthritis. Crystal formation in articular cartilage may play a major role in the onset of inflammation and cartilage destruction ([@bib10]; [@bib37]; [@bib32]). Calcification of cardiovascular tissues including arteries, heart valves, and cardiac muscle contributes to morbidity and mortality ([@bib13]).

Annexins II, V, and VI are highly expressed in hypertrophic and mineralizing growth plate cartilage and in bone. These molecules belong to the annexin protein family, which have in common that they bind to acidic phospholipids in the presence of calcium ([@bib9]; [@bib12]; [@bib32], [@bib33]). Annexin II and V each contain four 70--80 amino acid repeats with an annexin consensus sequence, whereas annexin VI contains eight such repeats. These four or eight repeats form the conserved core region, which is responsible for the Ca^2+^-dependent binding of the proteins to phospholipids. In contrast, the NH~2~-terminal regions of the annexins are highly variable and may contribute to the specific functions of the various annexins ([@bib11]). Previous studies have shown that annexins II, V, and VI form Ca^2+^ channels when inserted into artificial phospholipid bilayers or mediate Ca^2+^ influx into liposomes ([@bib3]; [@bib8]; [@bib2]; [@bib7]; [@bib36]; [@bib31]). Recently, we have demonstrated that annexins II, V, and VI form Ca^2+^ channels in matrix vesicles ([@bib31]). Matrix vesicles are particles that are released from the plasma membrane of mineralizing cells. These vesicles have the critical role of initiating the mineralization process ([@bib1]; [@bib29]). The first mineral phase forms inside the vesicles in a protected environment. Once these intralumenal crystals have reached a certain size they rupture the vesicle membrane and grow out into the extracellular matrix ([@bib1]). For the formation of the first intralumenal crystals, phase channel or transporter systems are required to mediate influx of mineral ions into the vesicles. Annexins II, V, and VI enable the influx of Ca^2+^ into matrix vesicles and the formation of the first intralumenal mineral phase. The inhibition of annexin Ca^2+^ channel activities led to a loss of the ability of these vesicles to mineralize ([@bib31]). Other studies have shown that matrix vesicles contain a Na^+^-coupled P~i~ symport system that mediates the influx of inorganic phosphate into the vesicles ([@bib38], [@bib39]). The total amounts of Ca^2+^ and P~i~ in matrix vesicles are significantly higher than those in adjacent cells or in the extracellular fluid. The vast majority of Ca^2+^ and about half of P~i~ are in insoluble, protein/lipid-bound form in the vesicles, which allows permanent annexin-mediated Ca^2+^ influx into the vesicles.

Ultrastructural studies have shown a high concentration of matrix vesicles in the reserve zone of growth plate cartilage and another peak concentration in the hypertrophic zone just before the onset of matrix mineralization ([@bib40]; [@bib6]). Furthermore, we have described a qualitative difference between vesicles released by the various growth plate chondrocytes, and that only mineralization-competent growth plate chondrocytes release specialized matrix vesicles that are capable of initiating the mineralization process, whereas nonmineralizing growth plate chondrocytes release vesicles that do not mineralize ([@bib29], [@bib30]). Thus, it is reasonable to hypothesize that chondrocytes regulate the mineralization process by controlling the release of specialized matrix vesicles and that only mineralization-competent chondrocytes release matrix vesicles that initiate the mineralization process. However, very little is known about the mechanisms involved in regulating the release of these mineralization-competent matrix vesicles from the plasma membrane of growth plate chondrocytes.

Calcium is recognized as an important regulatory element for many cellular processes. Increase in the cytosolic calcium concentration, \[Ca^2+^\]~i~, which occurs in many cell types after stimulation by hormones, controls a diverse range of cell functions including adhesion, motility, gene expression, and proliferation. Several studies have provided evidences that growth plate chondrocytes accumulate large amounts of cytosolic calcium just before the initiation of mineralization ([@bib17]; [@bib26]; [@bib19]). Nevertheless, little is known about the mechanisms involved in alterations of Ca^2+^ homeostasis in growth plate chondrocytes and the role of altered Ca^2+^ homeostasis in chondrocyte differentiation and mineralization. Interestingly, vesiculation or ectocytosis of the plasma membrane has been shown to be dependent on an influx of calcium in the cytoplasm of many cell types. For example, Ca^2+^ ionophores can cause microvesiculation and membrane shedding in a variety of cell types including chondrocytes, fibroblasts, neutrophils, and platelets ([@bib43]; [@bib19]; [@bib5]). Thus, it is possible that annexins II, V, and VI form Ca^2+^ channels in hypertrophic growth plate chondrocytes leading to influx of Ca^2+^ and alterations of Ca^2+^ homeostasis. The altered Ca^2+^ homeostasis leads to the release of annexin-containing, mineralization-competent matrix vesicles.

Previously we and others have shown that retinoic acid (RA)[\*](#fn1){ref-type="fn"} affects the release of annexin-containing matrix vesicles and stimulates mineralization of hypertrophic growth plate chondrocytes ([@bib21]; [@bib30]). To test our hypothesis that annexin-mediated alterations in Ca^2+^ homeostasis of growth plate chondrocytes might regulate the mineralization process of growth plate chondrocytes, we cultured hypertrophic growth plate chondrocytes in the presence of RA and 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM), a cell permeable Ca^2+^ chelator, K-201, a specific annexin Ca^2+^ channel blocker ([@bib23]; [@bib24]; [@bib31]), or antibodies specific for annexin II, V, or VI. We measured changes in \[Ca^2+^\]~i~, and characterized matrix vesicles isolated from these cultures and the degree of mineralization in these cultures.

Results
=======

Alteration in Ca^2+^ homeostasis and mineralization of growth plate chondrocytes
--------------------------------------------------------------------------------

We and others have shown that RA treatment stimulates mineralization of hypertrophic growth plate chondrocytes ([@bib21]; [@bib30]). In addition, hypertrophic differentiation of chondrocytes is accompanied by an increase in \[Ca^2+^\]~i~ ([@bib18]; [@bib17]; [@bib26]). Since alterations in Ca^2+^ homeostasis affect differentiation processes in many cell types, we first determined whether RA treatment alters Ca^2+^ homeostasis of growth plate chondrocytes. As shown in [Fig. 1, 1-d](#fig1){ref-type="fig"} treatment of chondrocytes isolated from the hypertrophic zone of 19-d embryonic chick tibia growth plate cartilage with RA led to an approximately threefold increase in \[Ca^2+^\]~i~ (\[Ca^2+^\]~i~ of untreated chondrocytes, 887 nM; \[Ca^2+^\]~i~ of RA-treated chondrocytes, 2,867 nM). Cotreatment of growth plate chondrocytes with RA and EDTA abolished the increase in \[Ca^2+^\]~i~, indicating that the increase in \[Ca^2+^\]~i~ was due to the influx of extracellular Ca^2+^ into the cells.

![**Cytosolic calcium concentration of untreated, RA- and RA/EDTA-treated growth plate chondrocytes.** After growth plate chondrocytes isolated from 19-d chick embryonic tibia reached confluency, the cells were cultured in the absence or presence of 35 nM RA, or RA and 5 mM EDTA for 1 d. The cytosolic calcium concentration, \[Ca^2+^\]~i~, of chondrocytes was measured using fura-2AM as described in Materials and methods. Data were obtained from four different experiments and values are mean ± SD. (★, *P* ≤ 0.01 vs. untreated cultures.)](0203014f1){#fig1}

To determine whether the increase in \[Ca^2+^\]~i~ affects mineralization of growth plate chondrocytes, we treated cells with RA and BAPTA-AM. After 6-d treatment with RA, cultures were heavily calcified as indicated by the intense alizarin red S staining ([Fig. 2](#fig2){ref-type="fig"}). In contrast untreated or RA/BAPTA-treated cultures showed significantly less alizarin red S staining ([Fig. 2](#fig2){ref-type="fig"}). Alkaline phosphatase (APase) activity, an enzyme whose activity is up-regulated just before the onset of mineralization ([@bib4]), was also significantly increased in RA-treated cells compared with the APase activities in untreated or RA/BAPTA-treated cells ([Fig. 3](#fig3){ref-type="fig"}).

![**Extent of matrix mineralization in chondrocyte cultures treated with RA or RA/BAPTA.** Growth plate chondrocytes were treated with RA or RA and BAPTA for 6 d. (A) Note the intense alizarin red S staining in cultures treated with RA. In contrast, less staining was detected in untreated or RA/BAPTA-treated cultures. (B) To quantitate the alizarin red S stain, each dish was incubated with 100 mM cetylpyridium chloride for 1 h. The alizarin red stain released into solution was collected, diluted when necessary, and read as units of alizarin red released (1 unit is equivalent to 1 unit optical density at 570 nm) per mg of protein. Data were obtained from four different experiments and values are mean ± SD. (★, *P* ≤ 0.01 vs. untreated cultures.)](0203014f2){#fig2}

![**Alkaline phosphatase (APase) activity in untreated, RA-, and RA/BAPTA-treated chondrocyte cultures.** After 6-d treatment, APase activity in the cell layer of RA-treated was significantly higher than APase activities in untreated or RA/BAPTA-treated cultures. Data were obtained from four different experiments; values are mean ± SD. (★, *P* ≤ 0.01 vs. untreated cultures.)](0203014f3){#fig3}

Previous studies have shown that matrix vesicles, which are released from the plasma membrane of mineralizing chondrocytes, initiate the mineralization process ([@bib1]; [@bib29]). In addition, we have demonstrated that only matrix vesicles that contain annexins II, V, and VI, and APase were able to initiate mineralization ([@bib29]). To test if alterations of Ca^2+^ homeostasis affect matrix vesicle release and/or composition, we isolated matrix vesicles from untreated, RA-treated, and RA/BAPTA-treated cultures and compared their composition and functions. APase activity ([Fig. 4](#fig4){ref-type="fig"}) and the amount of annexins II, V, and VI ([Fig. 5](#fig5){ref-type="fig"}) were significantly increased in matrix vesicles isolated from RA-treated cultures compared with vesicles isolated from untreated cultures. Matrix vesicles isolated from RA-treated chondrocytes were able to take up significant amounts of Ca^2+^ when incubated in synthetic cartilage lymph for 24 h. In contrast, vesicles isolated from untreated cultures were not able to take up significant amounts of Ca^2+^ ([Fig. 6](#fig6){ref-type="fig"}), confirming our previous findings that only vesicles containing Ca^2+^ channels formed by annexin II, V, and VI are able to take up Ca^2+^ ([@bib29], [@bib31]). Interestingly, matrix vesicles isolated from RA/BAPTA-treated cultures showed similar properties as vesicles isolated from untreated cultures. These vesicles contained little APase activity, annexins II, V, and VI, and showed no significant Ca^2+^ uptake ([Figs. 4](#fig4){ref-type="fig"}--[6](#fig6){ref-type="fig"}). These findings indicate that alterations of Ca^2+^ homeostasis in growth plate chondrocytes regulate the release of mineralization-competent matrix vesicles and subsequent mineralization.

![**Alkaline phosphatase (APase) activity in matrix vesicles isolated from untreated, RA- and RA/BAPTA-treated growth plate chondrocytes.** After 3 d, matrix vesicles were isolated from the cell layer of untreated, RA-, and RA/BAPTA-treated chondrocytes as described in Materials and methods. APase activity was \>10-fold increased in matrix vesicles isolated from RA-treated cultures compared with the activity in vesicles isolated from untreated or RA/BAPTA-treated cultures. Data were obtained from four different experiments; values are mean ± SD. (★, *P* ≤ 0.01 vs. APase activity of vesicles isolated from untreated cultures.)](0203014f4){#fig4}

![**Amount of annexins II, V, and VI in matrix vesicles isolated from untreated, RA- or RA/BAPTA-treated chondrocytes.** Matrix vesicle fractions (50 μg of total protein) isolated from 3-d untreated, RA-, or RA/BAPTA-treated cultures were subjected to SDS-PAGE and immunoblotting using antibodies specific for annexin II, V, or VI (A). The optical densities of the annexin bands were quantitated by densitometry. The optical densities obtained for annexin bands in matrix vesicle fractions isolated from untreated cultures were set as 1. Data were obtained from four different experiments; values are mean ± SD. (★, *P* ≤ 0.01 vs. vesicles isolated from untreated cultures.)](0203014f5){#fig5}

![**Ca** ^2**+**^ **uptake by matrix vesicles isolated from untreated, RA-, and RA/BAPTA-treated chondrocytes.** Matrix vesicles were isolated from 3-d untreated, RA- or RA/BAPTA-treated chondrocytes. The vesicle fractions (100 μg of total protein) were incubated in synthetic cartilage lymph for 24 h at 37°C and Ca^2+^ uptake of these vesicle fractions was measured as described in Materials and methods. Note that only vesicles isolated from RA-treated cultures showed significant Ca^2+^ uptake, whereas vesicles isolated from untreated or RA/BAPTA-treated cultures showed no significant Ca^2+^ uptake. Ca^2+^ uptake by matrix vesicles isolated from RA-treated cultures was set as 1. Data were obtained from four different experiments; values are mean ± SD.](0203014f6){#fig6}

Annexins mediate Ca^2+^ influx into growth plate chondrocytes
-------------------------------------------------------------

Based on our previous findings showing that annexins II, V, and VI form Ca^2+^ channels in matrix vesicles enabling Ca^2+^ influx into these particles ([@bib31]), we hypothesized that these annexins might also form Ca^2+^ channels in the plasma membrane of growth plate chondrocytes, thereby regulating Ca^2+^ homeostasis and ultimately mineralization. First, we tested whether the amount of membrane-bound annexins increased in RA-treated cultures. Indeed, 3-d treatment of chondrocytes with RA led to a significant relocation of annexins II, V, and VI from the cytoplasm to the plasma membrane. Cotreatment with BAPTA reduced the amount of plasma membrane--bound annexin II, V, and VI to levels similar as in untreated cultures ([Fig. 7](#fig7){ref-type="fig"}). Next, we tested whether RA treatment not only leads to a relocation of annexins to the plasma membrane, but also to Ca^2+^ channel formation. Therefore, we cotreated growth plate chondrocytes with RA and the specific annexin Ca^2+^ channel blocker K-201 and measured \[Ca^2+^\]~i~ after 1-d treatment. As shown above, RA treatment led to more than threefold increase in \[Ca^2+^\]~i~ compared with the levels in untreated cultures. Interestingly, K-201 significantly reduced this increase in RA-treated cultures. \[Ca^2+^\]~i~ was only slightly higher in RA/K-201-treated cultures compared with untreated cultures, indicating that the majority of the increased \[Ca^2+^\]~i~ in growth plate chondrocytes is due to the influx of Ca^2+^ through annexin channels ([Fig. 8](#fig8){ref-type="fig"}). Finally, to test whether all three annexins form Ca^2+^ channels in the plasma membrane, we treated chondrocyte cultures with RA and antibodies specific for annexin II, V, or VI. The anti--annexin V IgG fraction decreased RA-mediated increase in \[Ca^2+^\]~i~ by 75%, the anti--annexin VI IgG fraction by 65%, and the anti--annexin II IgG fraction by 57%, indicating that all three annexins form Ca^2+^ channels in the plasma membrane of growth plate chondrocytes and mediate Ca^2+^ influx into these cells ([Fig. 8](#fig8){ref-type="fig"}).

![**Amount of annexin II, V, or VI bound to the plasma membrane of untreated, RA-, and RA/BAPTA-treated growth plate chondrocytes.** The membrane and cytosolic fractions were isolated from 3-d untreated, RA-, or RA/BAPTA-treated chondrocytes and analyzed by SDS-PAGE and immunoblotting using antibodies specific for annexin II, V, or VI. The optical densities of the annexin bands in membrane and cytosolic fractions were quantitated by densitometry. Data were obtained from four different experiments; values are mean ± SD. (★, *P* ≤ 0.01 vs. untreated cultures.)](0203014f7){#fig7}

![**Cytosolic calcium concentration in untreated, RA-, RA/K-201-, RA/anti--annexin II IgG, RA/anti--annexin V IgG, RA/anti--annexin VI IgG-treated chondrocytes.** \[Ca^2+^\]~i~ in chondrocytes was measured after 1-d treatment with RA, RA/K-201, RA/anti--annexin II IgG, RA/anti--annexin V IgG, and RA/anti--annexin VI IgG as described in Materials and methods. Data were obtained from four different experiments and values are mean ± SD. (★, *P* ≤ 0.01 vs. RA-treated cultures.)](0203014f8){#fig8}

Interestingly, annexin-mediated Ca^2+^ influx into growth plate chondrocytes led to the up-regulation of their own gene expression. Real-time PCR analysis revealed a three- to sevenfold up-regulation of annexin II, V, and VI gene expression after 3- and 4-d treatment with RA. Chelation of cytosolic Ca^2+^ with BAPTA decreased up-regulation of annexin gene expression ([Fig. 9](#fig9){ref-type="fig"}, A--C). In this study chondrocytes were isolated from the hypertrophic zone of tibia growth plate cartilage, and thus these cells showed high expression levels of type X collagen. RA or RA/BAPTA treatment did not further increase these already high type X collagen expression levels ([Fig. 9](#fig9){ref-type="fig"} D). The fact that RA and RA/BAPTA treatment does not alter the high expression of type X collagen in growth plate chondrocytes reveals that these treatments do not change the chondrocytic phenotype.

![**Quantitative real time PCR analysis of annexin II, V, and VI, and type X collagen gene expression in chondrocytes treated with RA or RA/BAPTA.** Total RNA was isolated from 1- to 6-d untreated, RA-, and RA/BAPTA-treated chondrocytes. Annexin II, V, and VI, and type X collagen gene expression were detected by quantitative real-time PCR using SYBR Green. PCR reactions were run in triplicates. Data were obtained from triplicated PCR reactions of three different cultures and values are mean ± SD (★, *P* ≤ 0.01, ★★, *P* ≤ 0.05 vs. 1-d untreated cultures.)](0203014f9){#fig9}

Discussion
==========

Ca^2+^ homeostasis controls a diverse range of cellular functions including adhesion, motility, gene expression, proliferation, and differentiation. Interestingly, many studies have demonstrated that hypertrophic growth plate chondrocytes can accumulate large amounts of cytosolic calcium, suggesting that these increases might regulate chondrocyte differentiation and mineralization. Here we provide direct evidence that RA treatment, which has been shown to induce terminal differentiation and mineralization of growth plate chondrocytes ([@bib21]; [@bib30]), leads to an increase in \[Ca^2+^\]~i~. This increase regulates a whole series of events eventually leading to matrix mineralization of growth plate chondrocytes: up-regulation of annexin II, V, and VI gene expression, release of APase- and annexin II, V, and VI--containing matrix vesicles, and initiation of mineralization by these vesicles. Moreover, the increase in \[Ca^2+^\]~i~ during terminal differentiation of growth plate chondrocytes is to a large degree mediated by annexins II, V, and VI. These annexins form Ca^2+^ channels in the plasma membrane of RA-treated chondrocytes, enabling Ca^2+^ influx into these cells. Thus, through alteration of Ca^2+^ homeostasis in growth plate chondrocytes, annexins II, V, and VI regulate their own gene expression and subsequent release of annexin-containing, mineralization-competent matrix vesicles.

Our results reveal that under certain physiological conditions, annexins are able to form Ca^2+^ channels. These findings present a new concept to regulate Ca^2+^ homeostasis by annexin Ca^2+^ channels. Annexins are cytosolic proteins, which in the presence of Ca^2+^, can bind to acidic phospholipids. However, channel formation not only requires membrane binding, but also membrane insertion. Previous studies have provided evidence that annexins V, VI, and XII can insert into the membrane and form Ca^2+^ channels at low pH in a Ca^2+^-independent manner ([@bib20]; [@bib14],[@bib15]). For example, annexin VI undergoes major conformational changes under low pH that leads to an increase of hydrophobicity ([@bib14],[@bib15]). Furthermore, a biophysical study has demonstrated that the secondary structure of annexin V is affected by the combined interactions with Ca^2+^ and membrane components ([@bib44]). Interestingly, a recent study has shown that annexin V mediates peroxide-induced Ca^2+^ influx into B cells under physiological pH ([@bib35]). These and our findings indicate that the cell not only can regulate gene expression of annexins, but also their channel formation, allowing a precise regulation of the biological consequences of annexin channel formation. It is not clear which factors regulate physiological channel formation by annexins. It is possible that a certain Ca^2+^ concentration is required for membrane binding and channel formation. Other possibilities are that intracellular acidification or, as we have shown previously, the lipid composition of the membrane, may play regulatory roles in annexin channel formation ([@bib28]). Furthermore, a previous study has shown that vitamin D caused an increase in fluidity of the plasma membrane ([@bib41]). Thus, it is possible that RA has a similar effect on the plasma membrane that could favor annexin channel formation.

Our results and the findings showing that annexin V mediated peroxide-induced Ca^2+^ influx into B cells ([@bib35]) establish that annexin Ca^2+^ channels have important physiological functions in altering cell behavior and differentiation. In case of growth plate chondrocytes, annexin channel formation regulates Ca^2+^ homeostasis in these cells, and thereby the mineralization process including the release of mineralization-competent matrix vesicles. These vesicles contain annexins II, V, and VI as major components ([@bib12]). We have demonstrated that these annexins also form Ca^2+^ channels in matrix vesicles, allowing Ca^2+^ influx into these particles and the formation of the first mineral phase inside the vesicles ([@bib31]). Thus, these annexins not only regulate Ca^2+^ homeostasis in growth plate chondrocytes, but they also play a direct role in the initiation of mineralization. Interestingly, our data indicate that annexin-mediated Ca^2+^ influx into growth plate chondrocytes up-regulates annexin gene expression. Thus, these annexins regulate their own gene expression, thereby possibly enabling sufficient amounts of annexins II, V, and VI to be available for the release of mineralization-competent matrix vesicles.

\[Ca^2+^\]~i~ in hypertrophic chondrocytes is higher than the concentration in immature chondrocytes ([@bib18]; [@bib17]). As indicated by previous studies, this increase is most likely mediated by other Ca^2+^ channels than the annexins ([@bib47]; [@bib48]). Initial increased \[Ca^2+^\]~i~ might lead to annexin Ca^2+^ channel formation and subsequent further increase in \[Ca^2+^\]~i~. K-201 treatment, which inhibits Ca^2+^ channel activities of annexin II, V, and VI ([@bib31]), did not completely reduce RA-mediated increase in \[Ca^2+^\]~i~ to levels in untreated cultures. However, K-201 reduced the increase by ∼87%, indicating that the majority of Ca^2+^ influx into growth plate chondrocytes is mediated by annexins. There are several reasons why K-201 did not completely inhibit RA-mediated increase in \[Ca^2+^\]~i~. First, we have shown that the concentration of K-201 required to completely block annexin II--, V--, and VI--mediated Ca^2+^ influx into artificial liposomes or matrix vesicles is 100 μM ([@bib31]). However, 100 μM K-201 is toxic to chondrocytes (unpublished data). Thus, it is possible that 20 μM K-201, which was not toxic to the cells, might not completely block annexin channels. Another possibility is that growth plate chondrocytes contain other Ca^2+^ channels that might contribute to the Ca^2+^ influx into RA-treated chondrocytes. Previous characterizations of Ca^2+^ channels in growth plate chondrocytes are controversial. One study provided evidence that growth plate chondrocytes contain N-type Ca^2+^ channels, whereas another study suggested that growth plate chondrocytes contain L-type Ca^2+^ channels ([@bib47]; [@bib48]). Each antibody specific for annexin II, V, or VI decreased RA-mediated increase in \[Ca^2+^\]~i~ by between 57 and 75%, revealing that all three annexins contribute to Ca^2+^ influx into growth plate chondrocytes and blocking the channel activities of one annexin only partially reduces RA-mediated increase in \[Ca^2+^\]~i~. Thus, our findings indicate that the annexins contribute the majority to the alteration of Ca^2+^ homeostasis in RA-treated growth plate chondrocytes and thereby regulate the mineralization process.

Annexin-mediated Ca^2+^ influx into growth plate chondrocytes may be directly involved in the release of mineralization-competent matrix vesicles. Vesiculation or ectocytosis of the plasma membrane has been shown to be dependent on an influx of Ca^2+^ into the cytoplasm of many cell types. Ca^2+^ ionophores can cause microvesiculation and membrane shedding in a variety of cell types, including chondrocytes, fibroblasts, neutrophils, and platelets ([@bib43]; [@bib19]; [@bib5]). In contrast, when platelets were suspended in a solution containing EDTA, microparticle formation was inhibited ([@bib43]). Furthermore, we and others have provided evidence that matrix vesicles contain Ca^2+^-P~i~-phospholipid or nucleational core complex. This core complex is required for the formation of the first mineral phase inside the vesicles ([@bib27]; [@bib45]). There is some evidence to suggest that this complex might already be assembled at the plasma membrane of the cell before matrix vesicles are released ([@bib46]). Thus, it is possible that high \[Ca^2+^\]~i~ is required for the assembly of this complex.

Our study indicates that RA action is required for completion of the chondrocyte maturation process, and it provides the first important insight into the underlying mechanisms. Interestingly, a previous study demonstrated that the perichondral tissue surrounding the cartilage contained large amounts of retinoids and that implantation of beads containing RA antagonist near the humeral anlagen severely affected humerus development ([@bib34]). Thus, it is likely that RA plays an important role in regulating mineralization and terminal differentiation of growth plate chondrocytes in vivo.

In conclusion, our findings provide evidence that RA treatment of growth plate chondrocytes leads to Ca^2+^ channel formation by annexins II, V, and VI and influx of Ca^2+^ into these cells. The annexin-mediated alteration in Ca^2+^ homeostasis regulates a whole sequence of events eventually leading to matrix mineralization, including up-regulation of annexin II, V, and VI gene expression, relocation of these annexins to the plasma membrane, and release of APase- and annexin-containing matrix vesicles that initiate the mineralization process.

Materials and methods
=====================

Chondrocyte culture
-------------------

Chondrocytes were isolated from the hypertrophic zone of day 19 embryonic chick tibia growth plate cartilage as described previously ([@bib29]). In brief, sliced hypertrophic zone of growth plate cartilage was digested with 0.25% trypsin and 0.05% collagenase for 5 h at 37°C. Cells were plated at a density of 3 × 10^6^ into 10-cm tissue culture dishes and grown in monolayer cultures in DME (GIBCO BRL) containing 5% FCS (Hyclone), 2 mM [l]{.smallcaps}-glutamine (GIBCO BRL), and 50 U/ml penicillin and streptomycin (complete medium; GIBCO BRL). After cultures reached confluency, chondrocytes were cultured in the presence of 1.5 mM phosphate, and in the absence or presence of (a) 35 nM RA (Sigma-Aldrich), (b) 35 nM RA + 10 μM BAPTA-AM (Molecular Probes, Inc.), (c) 35 nM RA + 5 mM EDTA, (d) 35 nM RA + 20 μM 1,4-benzothiazepine derivative K-201 (JTV519) (provided by Drs. Noboro Kareko \[Dokkyo University, Tochigo, Japan\] and Toshizo Tanaka \[Japan Tobcco Inc., Osaka, Japan\]), or (e) 35 nM RA + 20 μg/ml IgG fractions specific for annexin II, V, or VI. \[Ca^2+^\]~i~ of chondrocytes was measured after 1-d treatment, matrix vesicles were isolated after 3-d treatment, and the degree of mineralization in these cultures was determined after 6-d treatment.

Measurement of \[Ca^2+^\]~i~
----------------------------

Chondrocytes were trypsinized first, and then 2 × 10^6^ cells were incubated with 4 μM of fura-2AM (Molecular Probes, Inc.) at 37°C for 15 min in complete medium. \[Ca^2+^\]~i~ was measured as described previously ([@bib26]). Briefly, labeled cells were resuspended in measuring buffer (\[mM\] 140 NaCl, 5 KCl, 1 CaCl~2~, 20 Hepes, 1 NaH~2~PO~4~, 5.5 glucose, pH 7.4), transferred to a cuvette (magnetically stirred), and fluorescence was measured in a fluorimeter (Photon Technology Instruments) using the excitation wavelength of 340 nm (Ca^2+^-bound form of fura-2AM) and the emission wavelength of 510 nm. The fluorescence maximum (F~max~) was determined by addition of 2 pM ionomycin (Calbiochem-Novabiochem), and the fluorescence minimum (F~min~) was determined in the presence of 1 mM EDTA/10 mM Tris. \[Ca^2+^\]~i~ was calculated according to the following equation: (\[Ca^2+^\]~i~ = *K* ~d~ × \[(F − F~min~)/(F~max~ − F)\] with *K* ~d~ = 224 nM ([@bib16]).

Isolation of total RNA and real-time PCR
----------------------------------------

Total RNA was isolated from chondrocyte cultures after 1-, 2-, 3-, 4-, 5-, and 6-d treatments using RNeasy Mini Kit (QIAGEN). 1 μg RNA was reverse transcribed using Ominiscript RT Kit (QIAGEN). Then a 1:100 dilution of the resulting cDNA was used as the template to quantitate the relative content of mRNA by real-time PCR (ABI PRISM 7700 sequence detection system) using respective primers and SYBR Green. The following primers for real-time PCR were designed using Primers Express software: annexin II, forward primer 5′-CATGCCTATCTGCTCTTCGTT-3′, reverse primer 5′-AGCCACCACACCGTCCATAA-3′; annexin V, forward primer 5′-AGAGACATCAGGCCATTTTCAGA-3′, reverse primer 5′-CTGCCATCAGGATCTCTATTTGC-3′; annexin VI, forward primer 5′-GCGGCTGATTGTAAGCTTGAT-3′, reverse primer 5′-GTCGGTGGTCCAGCACTTA-3′; and type X collagen, forward primer 5′-AGTGCTGTCATTGATCTCATGGA-3′, reverse primer 5′-TCAGAGGAATAGAGACCATTGGATT-3′. PCR reactions were performed with TaqMan PCR master mix kit (Applied Biosystems). The 18 S RNA was amplified at the same time and used as an internal control. The cycle threshold values for 18 S RNA and that of the samples were measured and calculated by computer software. Relative transcript levels were calculated as x = 2^−ΔΔCt^, in which ΔΔCt = ΔE − ΔC, and ΔE = Ct~exp~ − Ct~18S~; ΔC = Ct~ctl~ − Ct~18S~.

Isolation of matrix vesicles
----------------------------

Matrix vesicles were isolated from chondrocyte cultures by enzymatic digestion as described previously ([@bib29]). Briefly, adherent chondrocyte layers were washed with PBS and incubated with crude collagenase (500 U/ml; type IA; Sigma Chemical Co.) in HBSS at 37°C for 3 h. Matrix vesicles were harvested by different ultracentrifugation.

Ca^2+^ uptake by matrix vesicles
--------------------------------

Ca^2+^ uptake by matrix vesicles was assayed by incubating matrix vesicle aliquots (100 μg of protein) in 400 μl of synthetic cartilage lymph solution at 37°C for 24 h. After incubation, matrix vesicles were pelleted, washed twice in TNE buffer (TES pH 7.4, NaCl 1.5 mM and EDTA 2 μM), resuspended in TNE buffer containing 1 μM fura-2, transferred to a cuvette, and fluorescence was measured in fluorimeter using the excitation wavelength of 340 nm and the emission wavelength of 510 nm. Matrix vesicles were lysed with 1% Triton X-100 to release intravesicular calcium.

Recombinant annexin proteins and antibodies
-------------------------------------------

Recombinant annexins II, V, and VI were prepared using the pGEX expression vector (Amersham Pharmacia Biotech) as described previously ([@bib28]). The preparation of antibodies specific for annexins II, V, and VI were also described previously ([@bib32], [@bib33]).

SDS-PAGE and immunoblotting
---------------------------

Samples were dissolved in 3% SDS sample buffer with DTT, denatured at 100°C for 3 min, and analyzed by electrophoresis in 10 or 12% (wt/vol) SDS--polyacrylamide gels. Samples were electroblotted onto nitrocellulose filters after electrophoresis. After blocking with a solution of low-fat milk protein, blotted proteins were immunostained with primary antibodies followed by peroxidase-conjugated secondary antibody, and the signal was detected by enhanced chemiluminescene (Pierce Chemical Co.).

Measurement of APase activity and protein content
-------------------------------------------------

The measurements of APase activity and protein content were described previously ([@bib29]). Cells or vesicles were washed in PBS and suspended in 10 mM Tris-HCl, pH 7.5, 0.1% Triton X-100, and 0.5 mM MgCl~2~. Protein content was analyzed by BCA assay (Pierce Chemical Co.). APase activity was determined using *p*-nitrophenyl phosphate as a substrate ([@bib42]).

Alizarin red S staining
-----------------------

To determine the degree of mineralization in chondrocyte cultures, cultures were stained with alizarin red S. After washing, chondrocyte cultures were fixed with 70% ethanol for 10 min, and then stained with 0.5% alizarin red S in H~2~O, pH 4.0, for 5 min at room temperature. After staining, cultures were washed three times with H~2~O followed by 70% ethanol. To quantify matrix mineralization, the alizarin red S--stained cultures were incubated with 100 mM cetylpyridinium chloride for 1 h to solubilize and release calcium-bound alizarin red into solution ([@bib22]). The absorbance of the released alizarin red S was measured at 570 nm using a spectrophotometer. Data are expressed as units of alizarin red S released per milligram of protein in each culture.

Statistical analysis
--------------------

Numerical data are presented as mean + SD (*n* \> 4) and statistical significance between groups was identified using the two-tailed *t* test (*P* values are reported in the figure legends).
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